Patent Assignment
Reel/Frame 064203/0961
Assignment of Assignor's Interest
Recorded: 2023-07-10
Pages: 3
Assignor
AXEROVISION, INC.
Executed: 2023-06-28
Assignee
CS PHARMACEUTICALS LIMITED
LEVEL 30, THE LEADENHALL BUILDING, 122 LEADENHALL STREET, LONDON, EC3V 4AB, UNITED KINGDOM
Covered Property
(1)
Compositions and Methods of Use for Treating Aberrant Inflammation in Peri-Ocular Secretory Glands or at the Ocular Surface
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.